Landscapes / Targets

PARP1

15 drugs act on PARP1, in 28 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs15

DrugHow it worksCompanyStageNext dateDetails
PARP inhibitor
Approved in China —
PARP inhibitor
AstraZeneca · Public AZN
Phase 3 28 May 2027Phase 1/2 trial completes
—
Hengrui · Public 600276.SS
Phase 1/2 Dec 2026Phase 1/2 trial completes
—
Phase 2 Mar 2027Phase 2 trial completes
—
Phase 1/2 1 Jun 2027Phase 1/2 trial completes
—
Phase 1/2 Dec 2028Phase 1/2 trial completes
—
Phase 1/2 —
—
Phase 1/2 —
—
Phase 1 Dec 2026Phase 1 trial completes
—
Phase 1 22 Feb 2027Phase 1 trial completes
—
Phase 1 Aug 2028Phase 1 trial completes
—
Gilead (Kite) · Public GILD
Phase 1 Sep 2028Phase 1 trial completes
—
Phase 1 30 Dec 2028Phase 1 trial completes
—
Phase 1 —
—
Phase 1 —

About this list

Checked
15 of 15 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow PARP1

Following is part of Solo: you see every change to PARP1 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in